Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD

Phase: N/A Priority: Normal
NCT ID: NCT02694770 Org: User:
Start: 07/31/16 End: 02/28/18 Due: 02/28/19

A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02267642 Org: User:
Start: 01/31/15 End: 01/31/16 Due: 01/31/17

A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02908451 Org: User:
Start: 04/24/17 End: 02/28/21 Due: 02/28/22

An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01466569 Org: User:
Start: 11/30/11 End: 01/31/13 Due: 01/31/14

A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02436460 Org: User:
Start: 05/31/15 End: 03/31/16 Due: 03/31/17

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02223039 Org: User:
Start: 05/31/14 End: 02/28/15 Due: 02/28/16

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01855880 Org: User:
Start: 05/31/13 End: 03/31/14 Due: 03/31/15